期刊文献+

KL-6、SP-A 及SP-D对儿童间质性肺疾病早期诊断及预后的评估价值 被引量:4

Value of KL-6,SP-A and SP-D in Early Diagnosis and Prognosis Assessment of Interstitial Lung Disease in Children
下载PDF
导出
摘要 【目的】探讨血清涎液化糖链抗原(Krebs von den Lungen-6,KL-6)、肺表面活性物质-A(Surfactant protein A,SP-A)及肺表面活性物质-D(Surfactant protein D,SP-D)对儿童间质性肺疾病(Inter_(s)titial lung disease,ILD)早期诊断及预后的评估价值。【方法】选取2016年3月至2020年7月本院呼吸内科诊治的ILD患儿35例(ILD组),另外选取同期在本院诊治感染性肺炎患儿40例(肺炎组)以及40名健康体检儿童作为对照组,检测三组血清KL-6、SP-A、SP-D水平,并分析其对儿童ILD早期诊断及预后评估的价值。【结果】ILD组血清KL-6、SP-A、SP-D水平高于肺炎组和对照组(P<0.01)。ILD患儿血清KL-6水平与最大肺活量(VC_(max))、与一秒率(FEV1/FVC)呈正相关(r_(s)=0.339,P<0.05),SP-A水平与25%最大呼气流量(MEF25)呈负相关(r_(s)=-0.252,P<0.05);SP-D水平与VC_(max)呈负相关(r_(s)=-0.214,P<0.05);肺间质病变评分与KL-6、SP-A、SP-D呈正相关(r_(s)=0.542、0.618、0.515,P<0.01)。KL-6、SP-A、SP-D三者联合诊断ILD的AUC为0.89、敏感性为83.6%、特异性为97.2%、约登指数为0.81,联合检测对ILD的诊断价值显著高于单独检测(P<0.05)。KL-6、SP-A、SP-D为ILD患儿预后的影响因素(P<0.05)。【结论】KL-6、SP-A、SP-D可作为儿童ILD早期诊断、疾病严重程度及预后的评估指标,三者联合应用可提高诊断ILD的准确性。 【Objective】To analysis the value of Krebs von den Lungen-6(KL-6),lung Surfactant Protein A(SP-A)and lung Surfactant Protein D(SP-D)for the early diagnosis and prognosis assessment of inter_(s)titial lung disease(ILD)in children.【Methods】A total of 35 children with inter_(s)titial lung disease(ILD)hospitalized in Department of Respiratory Medicine of Hunan Children's Hospital from March 2016 to July 2020 were selected as the ILD group,while 40 children hospitalized with infectious pneumonia during the same period were selected as the pneumonia group and 40 healthy children volunteer_(s) were selected as the control group.Clinical data of children in the three groups were collected to detect pulmonary function indicator_(s) of children in the three groups.Kl-6 was detected by chemiluminescent enzyme immunoassay,and SP-A and SP-D were detected by enzyme-linked immunoassay.The value of all three factor_(s) in early diagnosis and prognosis evaluation of inter_(s)titial pulmonary disease was analyzed.【Results】The levels of KL-6,SP-A and SP-D in ILD group were higher than those in pneumonia group and control group(P<0.01).The level of serum KL-6 was positively correlated with maximum vital capacity(VC_(max))and one second rate(FEV1/FVC)(r_(s)=0.339,P<0.05),while the level of SP-A was negatively correlated with 25%maximum expiratory flow(MEF25)(r_(s)=-0.252,P<0.05)and the level of SP-D was negatively correlated with VC_(max)(r_(s)=-0.214,P<0.05).Pulmonary inter_(s)titial lesion score was positively correlated with KL-6,SP-A and SP-D(r_(s)=0.542、0.618、0.515,P<0.01).The AUC,sensitivity,specificity and Youden index of KL-6,SP-A and SP-D combined detection were 0.89,83.6%,97.2%and 0.81,respectively,indicating that the combined detection of three parameteer_(s) was better than the single detection in the diagnosis of ILD.KL-6,SP-A and SP-D were the influencing factor_(s) for the prognosis of ILD children(P<0.05).【Conclusion】KL-6,SP-A and SP-D can be used as indicator_(s) of early diagnosis,disease severity and prognosis of inter_(s)titial lung disease in children,and their combined detection application can improve the diagnostic accuracy.
作者 段效军 张喜 安照辉 孟燕妮 李林瑞 陈艳萍 DUAN Xiao-jun;ZHANG Xi;AN Zhao-hui(Department of Respiratory,Hunan Children's Hospital,Changsha,Hunan 410007)
出处 《医学临床研究》 CAS 2022年第1期5-8,12,共5页 Journal of Clinical Research
基金 湖南省卫生健康委员会科研计划课题项目(编号:20200609)。
关键词 肺疾病 间质性 肺表面活性物质相关蛋白质A/血液 肺表面活性物质相关蛋白质D/血液 诊断 预后 儿童 Lung Diseases Interstitial Pulmonary Surfactant-Associated Protein A/BL Pulmonary Surfactant-Associated Protein D/BL Diagnosis Prognosis Child
  • 相关文献

参考文献4

二级参考文献23

  • 1刘传合,李硕,宋欣,陈超,赵京,陈育智.脉冲振荡肺功能支气管舒张试验阳性标准的确定[J].中华儿科杂志,2005,43(11):838-842. 被引量:24
  • 2张皓,肖现民,郑珊,蔡映云,佘红英,王立波.1002例4岁以下小儿潮气呼吸流速-容量环正常值的研究[J].临床儿科杂志,2006,24(6):486-488. 被引量:57
  • 3中华医学会儿科学分会呼吸学组全国儿童弥漫性实质性肺疾病/间质性肺疾病协作组.小儿间质性肺疾病14例临床-影像-病理诊断分析[J].中华儿科杂志,2011,49:92-97.
  • 4Vece TJ, Fan LL. Diagnosis and management of diffuse lung disease in children. Paediatr Respir Rev, 2011,12:238-242.
  • 5Dinwiddie R, Sharief N, Crawford O. Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol, 2002, 34:23-29.
  • 6Hartl D, Griese M. Interstitial lung disease in children-genetic background and associated phenotypes. Respir Res,2005, 6:32.
  • 7Fan LL, Kozinetz CA. Factors influencing survival in children with chronic interstitial lung disease. Am J Respir Crit Care Med, 1997. 156(3 Pt 1) :939-942.
  • 8Eber EA. Interstitial lung diseases in infants and children. Eur Respir J, 2008, 31: 658-666.
  • 9Clement A, Nathan N, Epaud R, et al. Interstitial lung diseases in children. Orphanet J Rare Dis, 2010, 5:22.
  • 10Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med, 2007, 176 : 1120-1128.

共引文献340

同被引文献50

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部